Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.21+0.01 (+6.06%)
Close on Nov 17, 2026Market cap $947.51KP/E –Yield –
Oragenics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Oragenics's operating income for the twelve months ending Jun 30, 2026 was -$10.47M. For fiscal 2025 it was -$9.36M. The highest annual figure on record is -$5.82M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.36M | – |
| FY2024 | Dec 31, 2024 | -$10.56M | – |
| FY2023 | Dec 31, 2023 | -$20.90M | – |
| FY2022 | Dec 31, 2022 | -$14.42M | – |
| FY2021 | Dec 31, 2021 | -$15.77M | – |
| FY2020 | Dec 31, 2020 | -$26.64M | – |
| FY2019 | Dec 31, 2019 | -$15.88M | – |
| FY2018 | Dec 31, 2018 | -$9.99M | – |
| FY2017 | Dec 31, 2017 | -$6.72M | – |
| FY2016 | Dec 31, 2016 | -$8.54M | – |
| FY2015 | Dec 31, 2015 | -$11.78M | – |
| FY2014 | Dec 31, 2014 | -$5.82M | – |
| FY2013 | Dec 31, 2013 | -$16.21M | – |
| FY2012 | Dec 31, 2012 | -$12.43M | – |
| FY2011 | Dec 31, 2011 | -$7.35M | – |
| FY2010 | Dec 31, 2010 | -$7.90M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.59M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.26M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.71M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.03M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.36M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.31M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.46M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.80M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.09M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.11M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.90M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.91M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.60M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.61M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.30M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.39M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.84M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.24M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.55M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.51M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.35M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.23M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.66M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.92M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.90M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.39M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.82M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.28M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.12M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.41M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.92M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.40M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.99M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.71M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.03M | – |
See a number that looks wrong?